+629.1%
MRNA vs ED
+73.5%
+555.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ED | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.7% | -2.6% | -3.3% |
| 7D | -10.1% | -0.2% | -9.9% | -10.1% |
| 30D | +126.7% | +1.9% | +124.8% | +126.1% |
| 3M | +184.1% | +1.9% | +182.3% | +183.0% |
| 6M | +143.3% | -2.3% | +145.5% | +143.4% |
| YTD | +359.9% | +10.9% | +349.0% | +351.2% |
| 1Y | +454.2% | +14.5% | +439.7% | +440.9% |
| 3Y | +26.0% | +33.4% | -7.4% | +17.4% |
| 5Y | -70.3% | +67.3% | -137.5% | -73.4% |
| All | +629.1% | +73.5% | +555.6% | +478.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ED.
Daily Out/Under-Performance
Portfolio return minus ED return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ED return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ED wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling